Journal
JOURNAL OF PEDIATRIC ONCOLOGY NURSING
Volume 34, Issue 1, Pages 5-12Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1043454216659448
Keywords
immunotherapy; infusion management; patient safety
Ask authors/readers for more resources
Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
